Cargando…

The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation

NKG2C+ natural killer (NK) cell plays a vital role in CMV infection control after hematopoietic stem cell transplantation (HSCT). However, the modulation on NKG2C+ NK cell reconstitution is still unclear. NK cell education is affected by the interactions of HLA-I/killer immunoglobulin receptor (KIR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Wei, Yu, Xing-Xing, Liu, Xue-Fei, Chang, Ying-Jun, Wang, Yu, Zhang, Xiao-Hui, Xu, Lan-Ping, Liu, Kai-Yan, Zhao, Xiao-Su, Huang, Xiao-Jun, Zhao, Xiang-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101514/ https://www.ncbi.nlm.nih.gov/pubmed/35572602 http://dx.doi.org/10.3389/fimmu.2022.814334

Ejemplares similares

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals
por: Cassidy, Sorcha, et al.
Publicado: (2014)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
por: Moradi, Shoeib, et al.
Publicado: (2021)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
por: Morales, Raquel, et al.
Publicado: (2023)

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells
por: Sim, Malcolm J. W., et al.
Publicado: (2015)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
por: La, David, et al.
Publicado: (2011)

KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation
por: Legaz, Isabel, et al.
Publicado: (2019)

Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity
por: Bortolotti, Daria, et al.
Publicado: (2022)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

A novel full‐length two‐domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A*0010104
por: van Pul, Lisa, et al.
Publicado: (2020)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles
por: Bari, Rafijul, et al.
Publicado: (2016)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
por: Vojvodić, S, et al.
Publicado: (2015)

NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade
por: Lee, Grace, et al.
Publicado: (2023)

A novel antibody combination to identify KIR2DS2(high) natural killer cells in KIR2DL3/L2/S2 heterozygous donors
por: Blunt, Matthew D., et al.
Publicado: (2019)

The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis
por: Nishimura, Wester Eidi, et al.
Publicado: (2015)

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer
por: He, Yayi, et al.
Publicado: (2016)

The KIR2DL1 intermediate upstream element participates in gene activation
por: Wright, Paul W., et al.
Publicado: (2023)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Single Nucleotide Polymorphism in KIR2DL1 Is Associated With HLA-C Expression in Global Populations
por: Vargas, Luciana de Brito, et al.
Publicado: (2020)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection
por: Hu, Song, et al.
Publicado: (2022)

Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma
por: Bortolotti, Daria, et al.
Publicado: (2022)

Characterization of KIR (+) NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
por: Meazza, Raffaella, et al.
Publicado: (2022)

KIR2DL4 (CD158d): An activation receptor for HLA-G
por: Rajagopalan, Sumati, et al.
Publicado: (2012)

Deciphering the biology of KIR2DL3(+) T lymphocytes that are associated to relapse in haploidentical HSCT
por: David, Gaëlle, et al.
Publicado: (2021)

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
por: Zheng, Guoxu, et al.
Publicado: (2022)

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
por: Graef, Thorsten, et al.
Publicado: (2009)

异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
Publicado: (2017)

Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression
por: Niu, Chao, et al.
Publicado: (2018)

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression
por: Wright, Paul W., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4os61vgqcq4n8fb2efbklp1863